
Deinove acquires FDA-Fast Track antibiotic compound
MCB3837 is a water-soluble injectable small-molecule prodrug of the active substance MCB3681, which is being developed for the treatment of...

Ose and Boehringer ink €1.1bn deal in immunoncology
Under the agreement Boehringer Ingelheim will pay €15m upfront and additional €15m to Ose Immunotherapeutics for starting Phase I testing of OSE-172...

Servier to bag Shire's cancer business
The deal includes the acute lymphoblastic leukemia (ALL) drug pegaspargase (Oncaspar) and late stage ALL candidate drug calaspargase...

MYR Pharma completes chronic hepatitis delta POC trial
In February, the company had announced that Myrcludex B + interferon treatment was well tolerated by 60 patients with chronic hepatitis D during the...

GSK pass orphan gene therapy assets to Orchard Therapeutics
Under the strategic agreement GSK transfers its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the...

Palbociclib companion biomarker unraveled
Investigating the drug’s mode of action the researchers headed by Matthias Trost and Mikael Björklund identified the proteasome as new target of...

Stroke alarmin spurs further embolies
In Science Translational Medicine, the team headed by Arthur Liesz from LMU Munich report that the alarmin...